BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38711118)

  • 1. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
    Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
    Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
    Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
    J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
    Okura T; Higuchi K; Kitamura A; Deguchi Y
    Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
    Ozgür B; Saaby L; Janfelt C; Langthaler K; Eneberg E; Jacobsen AM; Badolo L; Montanari D; Brodin B
    Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
    Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
    J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrilamine-sensitive proton-coupled organic cation (H
    Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
    J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
    Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
    Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
    Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
    J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
    Higuchi K; Kitamura A; Okura T; Deguchi Y
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study.
    Bällgren F; Hammarlund-Udenaes M; Loryan I
    Pharm Res; 2023 Nov; 40(11):2715-2730. PubMed ID: 37610619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mystery of the human proton-organic cation antiporter: One transport protein or many?
    Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
    Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein.
    Evans DC; O'Connor D; Lake BG; Evers R; Allen C; Hargreaves R
    Drug Metab Dispos; 2003 Jul; 31(7):861-9. PubMed ID: 12814962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.
    Doetsch DA; Ansari S; Jensen O; Gebauer L; Dücker C; Brockmöller J; Sachkova A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
    Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
    Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
    Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
    Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
    Kitamura A; Higuchi K; Kurosawa T; Okura T; Kubo Y; Deguchi Y
    Biol Pharm Bull; 2022; 45(10):1585-1589. PubMed ID: 36184519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
    Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
    Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
    J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
    Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
    Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.